• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ASTROTECH LAUNCHES THE AgLAB-1000-D2 MAXIMUM VALUE PROCESSING CONTROL SYSTEM

By: Astrotech Corporation via GlobeNewswire
November 14, 2022 at 08:00 AM EST
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

AUSTIN, Texas, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) subsidiary, AgLAB, Inc. (AgLAB), today announced the launch of the AgLAB-1000-D2™ and the Maximum Value Processing™ (D2-MVP) control system. D2-MVP is a ruggedized mass-spectrometer that is designed for the cannabis and hemp processing lab and provides control over the distillation processes through “selected-point” testing of the processed oils. The D2-MVP control system has been designed to improve ending-weight yields, potencies, and revenues by as much as 45% as compared to traditional distillation methods. This technology is derivative of Astrotech subsidiary Astrotech Technologies Inc.’s (ATI) mass spectrometer technology.

“After multiple field tests, we believe the D2-MVP has demonstrated that our highly versatile ATI mass spectrometer technology can significantly improve customer processing results in many applications throughout the chemical manufacturing industry. Most process testing requires slow and cumbersome laboratory instruments that typically take many hours or even days to complete. With our rugged mass-spec and automatic calibration-tuning, the D2-MVP can be placed on the factory floor and typically produces processing results in less than a minute. This technological advancement makes it possible for the operator to perform many adjustments throughout the batch process while fine tuning for yields, color, and quality. We are very excited about introducing the D2-MVP, as we believe it is the first of its kind and is already being well received throughout the fast-growing hemp and cannabis industries,” said Thomas B. Pickens III, CEO of Astrotech and AgLAB.

About the AgLAB-1000-D2
The AgLAB-1000-D2 is the first ruggedized mass spectrometer that has been manufactured for use in assisting the chemical distillation of biomass. The chemical library and user interface can be easily customized for each processing application and is currently adapted to serve both the distillation of hemp CBD and cannabis THC oils.

This press release contains information about our new products under development, AgLAB-1000-D2 and the Maximum Value Processing™ control system. Product development involves a high degree of risk and uncertainty, and there can be no assurance that our new products will be successfully developed, achieve their intended benefits, receive full market authorization, or be commercially successful.

About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. AgLAB is developing chemical analyzers for use in the agriculture market. For more information, please visit www.astrotechcorp.com.

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include but are not limited to regulatory approvals required to market our products under development in the United States or abroad, whether the market will accept our products and services as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward-looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.


Jaime Hinojosa, Chief Financial Officer, Astrotech Corporation, (512) 485-9530

Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More
News headline image
Planet Labs: Coming Back Down to Earth ↗
Today 9:25 EDT
Via MarketBeat
Topics Initial Public Offering
Tickers PL
News headline image
Campbell's Q3 Earnings Call Highlights ↗
Today 9:06 EDT
Via MarketBeat
Topics Earnings Economy World Trade
Tickers CPB
News headline image
Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win ↗
Today 9:06 EDT
Via MarketBeat
Tickers ARM CMPX
News headline image
AstroNova Q1 Earnings Call Highlights ↗
Today 9:06 EDT
Via MarketBeat
Topics Earnings World Trade
Tickers ALOT
News headline image
Docusign: Another Beat, Another Selloff—Why the Analysts Are Wrong ↗
Today 8:50 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers DOCU HUBS

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.03
+0.00 (0.00%)
AAPL  307.34
+0.00 (0.00%)
AMD  466.38
+0.00 (0.00%)
BAC  53.83
+0.00 (0.00%)
GOOG  365.76
+0.00 (0.00%)
META  593.00
+0.00 (0.00%)
MSFT  416.67
+0.00 (0.00%)
NVDA  205.10
+0.00 (0.00%)
ORCL  213.68
+0.00 (0.00%)
TSLA  391.00
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap